Date | Time | Source | Headline | Symbol | Company |
05/30/2024 | 12:39PM | PR Newswire (US) | SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care | NASDAQ:SOPH | Sophia Genetics SA |
05/30/2024 | 12:19PM | PR Newswire (US) | SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care | NASDAQ:SOPH | Sophia Genetics SA |
05/29/2024 | 10:00AM | PR Newswire (US) | SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:09PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:09PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:08PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:08PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:08PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 9:07PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/20/2024 | 10:02AM | PR Newswire (US) | SOPHiA GENETICS Announces Instituto Mário Penna as New Customer | NASDAQ:SOPH | Sophia Genetics SA |
05/16/2024 | 6:02AM | PR Newswire (US) | Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS | NASDAQ:SOPH | Sophia Genetics SA |
05/15/2024 | 11:46AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SOPH | Sophia Genetics SA |
05/13/2024 | 4:24PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SOPH | Sophia Genetics SA |
05/07/2024 | 7:01AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SOPH | Sophia Genetics SA |
05/07/2024 | 6:45AM | GlobeNewswire Inc. | SOPHiA GENETICS Reports First Quarter 2024 Results | NASDAQ:SOPH | Sophia Genetics SA |
04/30/2024 | 7:05AM | GlobeNewswire Inc. | SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference | NASDAQ:SOPH | Sophia Genetics SA |
04/23/2024 | 10:29AM | GlobeNewswire Inc. | SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 | NASDAQ:SOPH | Sophia Genetics SA |
04/23/2024 | 5:05AM | PR Newswire (US) | SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa | NASDAQ:SOPH | Sophia Genetics SA |
04/17/2024 | 6:05AM | PR Newswire (US) | SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) | NASDAQ:SOPH | Sophia Genetics SA |
04/04/2024 | 1:00AM | PR Newswire (US) | SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership | NASDAQ:SOPH | Sophia Genetics SA |
04/04/2024 | 1:00AM | PR Newswire (US) | SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership | NASDAQ:SOPH | Sophia Genetics SA |
04/02/2024 | 10:00AM | PR Newswire (US) | Laboratorio Barnafi-Krause is Live on SOPHiA DDM™ | NASDAQ:SOPH | Sophia Genetics SA |
03/20/2024 | 10:00AM | PR Newswire (US) | SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada | NASDAQ:SOPH | Sophia Genetics SA |
03/15/2024 | 6:00AM | PR Newswire (US) | SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration | NASDAQ:SOPH | Sophia Genetics SA |
03/07/2024 | 12:07PM | GlobeNewswire Inc. | SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference | NASDAQ:SOPH | Sophia Genetics SA |
03/05/2024 | 7:02AM | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | NASDAQ:SOPH | Sophia Genetics SA |
03/05/2024 | 7:00AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SOPH | Sophia Genetics SA |
03/05/2024 | 6:45AM | GlobeNewswire Inc. | SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results | NASDAQ:SOPH | Sophia Genetics SA |
02/22/2024 | 8:45AM | GlobeNewswire Inc. | SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference | NASDAQ:SOPH | Sophia Genetics SA |
02/20/2024 | 10:46AM | GlobeNewswire Inc. | SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024 | NASDAQ:SOPH | Sophia Genetics SA |